Literature DB >> 27713606

Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries.

Jong Shiuan Yeh1, Seung Jin Oh2, Chun Mei Hsueh3.   

Abstract

BACKGROUND: We aimed to describe the frequency of vascular inflammatory reactions with second generation drug eluting stents (DES) compared to first generation DES, and analyze the impact on inflammation and neointimal proliferation in a porcine coronary model.
METHODS: A total of 26 stents (7 multi-link VISION, 6 CYPHER, 6 TAXUS and 7 XIENCE V) were deployed in the coronary arteries of 10 domestic swine for 28 days, after which each stent was harvested and processed (divided into 8 or 9 segments) for histomorphometric analysis.
RESULTS: A total of 202 histological segments [146 DES and 56 bare metal stents (BMS)] were included in this study. The mean neointimal thickness was significantly reduced in the DES group compared to the BMS group. The DES group had higher injury scores (DES = 0.99 ± 0.79 versus BMS = 0.67 ± 0.44, p < 0.004), inflammatory scores (DES = 2.09 ± 1.54 versus BMS = 0.64 ± 0.98, p < 0.001) and presence of para-strut granulomas (DES = 35% versus BMS = 2%, p < 0.001). In logistic regression analysis, the presence of para-strut granulomas correlated with an area of stenosis > 50% (RR: 6.11, 95% CI: 2.97 to 12.59, p = 0.001). In the DES group, the second generation stents had a lower neointimal area (XIENCE V: 1.64 ± 0.90 mm2) compared to the first generation stents (TAXUS: 2.36 ± 1.56 mm2, p = 0.005; CYPHER 2.78 ± 1.82 mm2, p = 0.001). The XIENCE V stents had lower inflammatory scores and lower frequency of para-strut granulomas compared to the first generation stents.
CONCLUSIONS: Second generation DES had a lower incidence of vascular inflammatory reactions compared to first generation DES. This biological phenomenon appears to influence the patterns of neointimal formation.

Entities:  

Keywords:  Drug eluting stent; Porcine coronary artery; Vascular inflammation reaction

Year:  2016        PMID: 27713606      PMCID: PMC5052476          DOI: 10.6515/acs20151013g

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  31 in total

Review 1.  The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents.

Authors:  Harry C Lowe; Robert S Schwartz; Briain D Mac Neill; Ik-Kyung Jang; Motoya Hayase; Campbell Rogers; Stephen N Oesterle
Journal:  Catheter Cardiovasc Interv       Date:  2003-12       Impact factor: 2.692

2.  Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.

Authors:  Raúl Moreno; Cristina Fernández; Rosana Hernández; Fernando Alfonso; Dominick J Angiolillo; Manel Sabaté; Javier Escaned; Camino Bañuelos; Antonio Fernández-Ortiz; Carlos Macaya
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

Review 3.  Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.

Authors:  Edoardo Camenzind; P Gabriel Steg; William Wijns
Journal:  Circulation       Date:  2007-03-07       Impact factor: 29.690

Review 4.  Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.

Authors:  Teruo Inoue; Kevin Croce; Toshifumi Morooka; Masashi Sakuma; Koichi Node; Daniel I Simon
Journal:  JACC Cardiovasc Interv       Date:  2011-10       Impact factor: 11.195

5.  Granulomatous 'foreign body reactions' contribute to exaggerated in-stent restenosis.

Authors:  R Kornowski; M K Hong; R Virmani; R Jones; Y Vodovotz; M B Leon
Journal:  Coron Artery Dis       Date:  1999       Impact factor: 1.439

6.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

Authors:  Jonathan R Nebeker; Renu Virmani; Charles L Bennett; Jennifer M Hoffman; Matthew H Samore; Jorge Alvarez; Charles J Davidson; June M McKoy; Dennis W Raisch; Brian K Whisenant; Paul R Yarnold; Steven M Belknap; Dennis P West; Jonathan E Gage; Richard E Morse; Gordana Gligoric; Laura Davidson; Marc D Feldman
Journal:  J Am Coll Cardiol       Date:  2005-12-01       Impact factor: 24.094

7.  Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent restenosis.

Authors:  C Yutani; H Ishibashi-Ueda; T Suzuki; A Kojima
Journal:  Cardiology       Date:  1999       Impact factor: 1.869

8.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.

Authors:  R Kornowski; M K Hong; F O Tio; O Bramwell; H Wu; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

9.  3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions).

Authors:  Scot Garg; Patrick Serruys; Yoshinobu Onuma; Cécile Dorange; Susan Veldhof; Karine Miquel-Hébert; Krishnankutty Sudhir; Jean Boland; Kurt Huber; Eulogio Garcia; Jan A M te Riele
Journal:  JACC Cardiovasc Interv       Date:  2009-12       Impact factor: 11.195

10.  Tight binding of albumin to glow discharge treated polymers.

Authors:  D Kiaei; A S Hoffman; T A Horbett
Journal:  J Biomater Sci Polym Ed       Date:  1992       Impact factor: 3.517

View more
  8 in total

1.  Systemic Inflammatory Response Syndrome is an Independent Predictor of One-Year Mortality in Patients with Acute Myocardial Infarction.

Authors:  Wei-Chieh Huang; Ruey-Hsing Chou; Chun-Chin Chang; Chien-Yi Hsu; Yu-Chen Ku; Hsiu-Fen Huang; Yi-Chieh Chen; Po-Hsun Huang
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

2.  Inhibitory Effect of Photodynamic Therapy with Indocyanine Green on Rat Smooth Muscle Cells.

Authors:  Jih-Shyong Lin; Chia-Jung Wang; Wen-Tyng Li
Journal:  Acta Cardiol Sin       Date:  2019-01       Impact factor: 2.672

3.  Anti-Inflammatory Effect of Gallic Acid-Eluting Stent in a Porcine Coronary Restenosis Model.

Authors:  Kyung Seob Lim; Jun-Kyu Park; Myung Ho Jeong; In Ho Bae; Dae Sung Park; Jae Won Shim; Jung Ha Kim; Hyun Kuk Kim; Sung Soo Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

4.  Stenting-induced Vasa Vasorum compression and subsequent flow resistance: a finite element study.

Authors:  Andrea Corti; Annalisa De Paolis; John Tarbell; Luis Cardoso
Journal:  Biomech Model Mechanobiol       Date:  2020-08-04

5.  Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents.

Authors:  Abhilash Akinapelli; Jack P Chen; Kristine Roy; Joseph Donnelly; Keith Dawkins; Barbara Huibregtse; Dongming Hou
Journal:  Curr Cardiol Rev       Date:  2017

Review 6.  Inflammation as a determinant of healing response after coronary stent implantation.

Authors:  Dorota Ochijewicz; Mariusz Tomaniak; Grzegorz Opolski; Janusz Kochman
Journal:  Int J Cardiovasc Imaging       Date:  2021-01-21       Impact factor: 2.357

7.  Real-World Comparison of Drug-Eluting and Bare-Metal Stents in Superficial Femoral Artery Occlusive Disease with Trans-Atlantic Intersociety Consensus B Lesions: A 2-Year, Single-Institute Study.

Authors:  Fan-Chieh Meng; Po-Lin Chen; Chiu-Yang Lee; Chun-Che Shih; I-Ming Chen
Journal:  Acta Cardiol Sin       Date:  2018-03       Impact factor: 2.672

Review 8.  The role of oxygen transport in atherosclerosis and vascular disease.

Authors:  John Tarbell; Marwa Mahmoud; Andrea Corti; Luis Cardoso; Colin Caro
Journal:  J R Soc Interface       Date:  2020-04-01       Impact factor: 4.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.